Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.085 USD | +1.50% | -2.20% | +21.21% |
11:15am | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
05-27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.21% | 292M | |
+10.36% | 114B | |
+10.65% | 105B | |
-4.64% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-16.90% | 16.13B | |
+2.58% | 13.75B | |
+32.30% | 11.76B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Transcript : Vanda Pharmaceuticals Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 12